371 related articles for article (PubMed ID: 37207228)
1. How Toll-like receptors influence Parkinson's disease in the microbiome-gut-brain axis.
Zhang Z; Liu Z; Lv A; Fan C
Front Immunol; 2023; 14():1154626. PubMed ID: 37207228
[TBL] [Abstract][Full Text] [Related]
2. TLR2 and TLR4 in Parkinson's disease pathogenesis: the environment takes a toll on the gut.
Gorecki AM; Anyaegbu CC; Anderton RS
Transl Neurodegener; 2021 Nov; 10(1):47. PubMed ID: 34814947
[TBL] [Abstract][Full Text] [Related]
3. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V; Giron MC
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease.
Drouin-Ouellet J; St-Amour I; Saint-Pierre M; Lamontagne-Proulx J; Kriz J; Barker RA; Cicchetti F
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522431
[TBL] [Abstract][Full Text] [Related]
5. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
Dogra N; Mani RJ; Katare DP
Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors and their therapeutic potential in Parkinson's disease and α-synucleinopathies.
Kouli A; Horne CB; Williams-Gray CH
Brain Behav Immun; 2019 Oct; 81():41-51. PubMed ID: 31271873
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology.
Dzamko N; Gysbers A; Perera G; Bahar A; Shankar A; Gao J; Fu Y; Halliday GM
Acta Neuropathol; 2017 Feb; 133(2):303-319. PubMed ID: 27888296
[TBL] [Abstract][Full Text] [Related]
8. From the Gut to the Brain: The Role of Enteric Glial Cells and Their Involvement in the Pathogenesis of Parkinson's Disease.
Montalbán-Rodríguez A; Abalo R; López-Gómez L
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279293
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Review on Potential Signaling Pathways Involving the Transfer of α-Synuclein from the Gut to the Brain That Leads to Parkinson's Disease.
Kumari S; Taliyan R; Dubey SK
ACS Chem Neurosci; 2023 Feb; 14(4):590-602. PubMed ID: 36724408
[TBL] [Abstract][Full Text] [Related]
10. Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis.
Claudino Dos Santos JC; Lima MPP; Brito GAC; Viana GSB
Ageing Res Rev; 2023 Feb; 84():101812. PubMed ID: 36455790
[TBL] [Abstract][Full Text] [Related]
11. Implications of the Gut Microbiome in Parkinson's Disease.
Elfil M; Kamel S; Kandil M; Koo BB; Schaefer SM
Mov Disord; 2020 Jun; 35(6):921-933. PubMed ID: 32092186
[TBL] [Abstract][Full Text] [Related]
12. α-Synuclein induces prodromal symptoms of Parkinson's disease via activating TLR2/MyD88/NF-κB pathway in Schwann cells of vagus nerve in a rat model.
Cheng Y; Tong Q; Yuan Y; Song X; Jiang W; Wang Y; Li W; Li Y; Zhang K
J Neuroinflammation; 2023 Feb; 20(1):36. PubMed ID: 36788559
[TBL] [Abstract][Full Text] [Related]
13. α-Synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells: an
Hurley MJ; Menozzi E; Koletsi S; Bates R; Gegg ME; Chau KY; Blottière HM; Macnaughtan J; Schapira AHV
Brain Commun; 2023; 5(6):fcad285. PubMed ID: 37953845
[TBL] [Abstract][Full Text] [Related]
14. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
[TBL] [Abstract][Full Text] [Related]
15. Microbiota- Brain-Gut-Axis Relevance to Parkinson's Disease: Potential Therapeutic Effects of Probiotics.
Raj K; Singh S; Chib S; Mallan S
Curr Pharm Des; 2022; 28(37):3049-3067. PubMed ID: 36200207
[TBL] [Abstract][Full Text] [Related]
16. Erythrocytic α-Synuclein and the Gut Microbiome: Kindling of the Gut-Brain Axis in Parkinson's Disease.
Yang Y; Stewart T; Zhang C; Wang P; Xu Z; Jin J; Huang Y; Liu Z; Lan G; Liang X; Sheng L; Shi M; Cai Z; Zhang J
Mov Disord; 2024 Jan; 39(1):40-52. PubMed ID: 37798868
[TBL] [Abstract][Full Text] [Related]
17. The gut in Parkinson's disease: Bottom-up, top-down, or neither?
Leclair-Visonneau L; Neunlist M; Derkinderen P; Lebouvier T
Neurogastroenterol Motil; 2020 Jan; 32(1):e13777. PubMed ID: 31854093
[TBL] [Abstract][Full Text] [Related]
18. Gut brain axis: an insight into microbiota role in Parkinson's disease.
Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M
Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 4 deficiency facilitates α-synuclein propagation and neurodegeneration in a mouse model of prodromal Parkinson's disease.
Venezia S; Kaufmann WA; Wenning GK; Stefanova N
Parkinsonism Relat Disord; 2021 Oct; 91():59-65. PubMed ID: 34530328
[TBL] [Abstract][Full Text] [Related]
20. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport.
Nielsen SD; Pearson NM; Seidler K
Brain Res; 2021 Oct; 1769():147609. PubMed ID: 34371014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]